CoolTech
North America, Ohio, United States, Toronto
Description
CoolTech develops transnasal cooling technology for non-invasive fever control and neuroprotection.
Investor Profile
CoolTech has made 1 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series A (100%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Service Industry
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
